AEON Biopharma, Inc.·4

Sep 4, 9:53 PM ET

Sy Jennifer 4

4 · AEON Biopharma, Inc. · Filed Sep 4, 2024

Insider Transaction Report

Form 4
Period: 2024-08-31
Sy Jennifer
PRINCIPAL ACCOUNTING OFFICER
Transactions
  • Award

    Class A Common Stock

    2024-08-31+18,01018,010 total
  • Award

    Stock Option

    2024-08-31+48,06348,063 total
    Exercise: $0.83Exp: 2034-08-30Class A Common Stock (48,063 underlying)
Footnotes (2)
  • [F1]Represents an award of restricted stock units granted on August 31, 2024 (the "Grant Date"), which vests in full on the second anniversary of the Grant Date, subject to the reporting person's continued service through the applicable vesting date.
  • [F2]Represents an award of stock options granted on August 31, 2024 (the "Grant Date"), which vest and become exercisable in substantially equal monthly installments over the eighteen months following the Grant Date, subject to the reporting person's continued service through the applicable vesting date.

Documents

1 file
  • 4
    tm2423415-4_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT